Trials / Active Not Recruiting
Active Not RecruitingNCT06073652
Starter Infant Formula With Synbiotics
Safety and Efficacy of a Starter Infant Formula With Synbiotics: a Double-blind, Randomized, Controlled Trial
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 14 Days – 35 Days
- Healthy volunteers
- Accepted
Summary
This randomized, double-blind, controlled intervention trial aims to evaluate the safety and efficacy of a starter infant formula supplemented with an HMO blend and a probiotic, and will provide evidence on the safety and efficacy of the innovative prebiotic/ probiotic blend to support age-appropriate infant growth, a healthy gut microbiome, gastrointestinal (GI) tolerance and GI health, and immune development.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Control 1st age starter infant formula | A standard bovine milk-based term infant formula. |
| OTHER | Experimental 1st age starter infant formula | Same content as Control formula plus supplemented with a HMO blend and a probiotic |
Timeline
- Start date
- 2023-07-05
- Primary completion
- 2024-08-14
- Completion
- 2027-09-01
- First posted
- 2023-10-10
- Last updated
- 2026-01-15
Locations
3 sites across 1 country: Philippines
Source: ClinicalTrials.gov record NCT06073652. Inclusion in this directory is not an endorsement.